Hillary Samples1, Ramin Mojtabai. 1. Ms. Samples is with the Department of Health Policy and Management and Dr. Mojtabai is with the Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (e-mail: hsamples@jhu.edu ).
Abstract
OBJECTIVE: The goal of this study was to examine the extent and correlates of self-discontinuation of antidepressant medications without physician advice. METHODS: Among 1,411 participants of the nationally representative Collaborative Psychiatric Epidemiology Surveys who reported using antidepressants in the past year, sociodemographic and clinical correlates of self-discontinuation of medication without physician advice or approval were examined, along with participants' reasons for discontinuation. RESULTS: A total of 313 (22%) antidepressant users in the preceding year reported discontinuing their antidepressant medication without physician advice or approval. Older individuals had reduced odds of self-discontinuing antidepressants. Participants with an anxiety or substance use disorder and those prescribed an antidepressant by a provider other than a psychiatrist had higher odds of self-discontinuation. Participants with public insurance had lower odds of self-discontinuation than those with private insurance. The two most commonly reported reasons for self-discontinuation of antidepressants were side effects and experiencing no benefit from the medication. CONCLUSIONS: Physicians prescribing antidepressants need to clearly communicate the expected benefits of treatment, the minimum duration of use required to experience benefits, and the potential side effects of these medications, particularly to younger patients, those with anxiety disorders, and patients treated in general medical settings, all of whom have increased odds of self-discontinuation.
OBJECTIVE: The goal of this study was to examine the extent and correlates of self-discontinuation of antidepressant medications without physician advice. METHODS: Among 1,411 participants of the nationally representative Collaborative Psychiatric Epidemiology Surveys who reported using antidepressants in the past year, sociodemographic and clinical correlates of self-discontinuation of medication without physician advice or approval were examined, along with participants' reasons for discontinuation. RESULTS: A total of 313 (22%) antidepressant users in the preceding year reported discontinuing their antidepressant medication without physician advice or approval. Older individuals had reduced odds of self-discontinuing antidepressants. Participants with an anxiety or substance use disorder and those prescribed an antidepressant by a provider other than a psychiatrist had higher odds of self-discontinuation. Participants with public insurance had lower odds of self-discontinuation than those with private insurance. The two most commonly reported reasons for self-discontinuation of antidepressants were side effects and experiencing no benefit from the medication. CONCLUSIONS: Physicians prescribing antidepressants need to clearly communicate the expected benefits of treatment, the minimum duration of use required to experience benefits, and the potential side effects of these medications, particularly to younger patients, those with anxiety disorders, and patients treated in general medical settings, all of whom have increased odds of self-discontinuation.
Authors: Rebecca C Rossom; Susan Shortreed; Karen J Coleman; Arne Beck; Beth E Waitzfelder; Christine Stewart; Brian K Ahmedani; John E Zeber; Greg E Simon Journal: Depress Anxiety Date: 2016-06-20 Impact factor: 6.505
Authors: John F Dickerson; Frances L Lynch; Michael C Leo; Lynn L DeBar; John Pearson; Gregory N Clarke Journal: Pediatrics Date: 2018-01-19 Impact factor: 7.124
Authors: Brandon Lippold; Yash R Tarkunde; Abby L Cheng; Charles P Hannon; Muyibat A Adelani; Ryan P Calfee Journal: Arthroplast Today Date: 2022-03-02
Authors: Shubha Bhat; Miranda E Kroehl; Katy E Trinkley; Zeta Chow; Lauren J Heath; Sarah J Billups; Danielle F Loeb Journal: Popul Health Manag Date: 2017-12-06 Impact factor: 2.459
Authors: Jo Anne Sirey; Samprit Banerjee; Patricia Marino; Martha L Bruce; Ashley Halkett; Molly Turnwald; Claire Chiang; Brian Liles; Amanda Artis; Fred Blow; Helen C Kales Journal: JAMA Psychiatry Date: 2017-11-01 Impact factor: 21.596
Authors: Carolyn L Turvey; Lindsey A Fuhrmeister; Dawn M Klein; Jane Moeckli; M Bryant Howren; Emily E Chasco Journal: Telemed J E Health Date: 2021-04-21 Impact factor: 3.536
Authors: Carla D Chugani; Tina R Goldstein; Rachel H Salk; Kim Poling; Dara Sakolsky; David Brent Journal: J Psychiatr Pract Date: 2020-03 Impact factor: 1.841
Authors: Paula Kopschina Feltes; Janine Doorduin; Hans C Klein; Luis Eduardo Juárez-Orozco; Rudi Ajo Dierckx; Cristina M Moriguchi-Jeckel; Erik Fj de Vries Journal: J Psychopharmacol Date: 2017-06-27 Impact factor: 4.153